This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It is particularly valuable in the development of drugs targeting central nervous system (CNS) disorders due to its structural properties that allow it to interact effectively with biological targets in the brain. Additionally, its trifluoromethyl group enhances its metabolic stability and bioavailability, making it a crucial component in the design of more potent and selective therapeutic agents. Researchers also explore its potential in creating novel anti-inflammatory and antimicrobial compounds, leveraging its unique chemical framework to improve efficacy and reduce side effects in clinical applications.